Abeona Therapeutics Inc (ABEO)
3.25
+0.08
(+2.52%)
USD |
NASDAQ |
Apr 25, 12:50
Abeona Therapeutics Gross Profit Margin (Quarterly)
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2023 | 55.00% |
| March 31, 2023 | |
| December 31, 2022 | -47.06% |
| September 30, 2022 | |
| June 30, 2022 | 65.00% |
| March 31, 2022 | |
| December 31, 2021 | |
| September 30, 2021 | |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | |
| September 30, 2020 | |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | |
| September 30, 2019 | |
| June 30, 2019 | |
| March 31, 2019 | |
| December 31, 2018 | |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | |
| September 30, 2017 | |
| June 30, 2017 |
| Date | Value |
|---|---|
| March 31, 2017 | |
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | |
| September 30, 2015 | |
| June 30, 2015 | |
| March 31, 2015 | |
| December 31, 2014 | |
| September 30, 2014 | |
| June 30, 2014 | |
| March 31, 2014 | |
| December 31, 2013 | |
| September 30, 2013 | 96.30% |
| June 30, 2013 | 88.65% |
| March 31, 2013 | 94.69% |
| December 31, 2012 | 93.44% |
| September 30, 2012 | 90.93% |
| June 30, 2012 | 90.87% |
| March 31, 2012 | 96.79% |
| December 31, 2011 | 91.77% |
| September 30, 2011 | 94.14% |
| June 30, 2011 | 75.33% |
| March 31, 2011 | 38.67% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
-47.06%
Minimum
Dec 2022
65.00%
Maximum
Jun 2022
24.31%
Average
55.00%
Median
Jun 2023
Gross Profit Margin (Quarterly) Benchmarks
| Perspective Therapeutics Inc | -- |
| Electromed Inc | 77.03% |
| Xtant Medical Holdings Inc | 60.97% |
| Asensus Surgical Inc | 21.47% |
| Senseonics Holdings Inc | 13.56% |